Keystone Investors PTE Ltd. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 25,065 shares of the medical equipment provider's stock, valued at approximately $13,083,000. Intuitive Surgical makes up 0.9% of Keystone Investors PTE Ltd.'s investment portfolio, making the stock its 21st biggest holding.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $36,000. Institutional investors own 83.64% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective for the company. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $611.86.
View Our Latest Research Report on ISRG
Insider Buying and Selling at Intuitive Surgical
In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the company's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG traded down $18.56 during midday trading on Friday, hitting $489.35. 1,145,477 shares of the stock traded hands, compared to its average volume of 1,522,274. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a 50 day moving average price of $558.29 and a two-hundred day moving average price of $532.25. The company has a market cap of $174.29 billion, a PE ratio of 76.34, a P/E/G ratio of 5.85 and a beta of 1.43.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.